or Try an Advanced Search...

    Technical Analysis for FBIOP - Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

    Grade Last Price % Change Price Change
    D 13.82 3.91% 0.52
    FBIOP closed up 3.91 percent on Friday, April 26, 2024, on 40 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical FBIOP trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Jack-in-the-Box Bearish Bearish Swing Setup 3.91%
    Lower Bollinger Band Walk Weakness 3.91%
    Inside Day Range Contraction 3.91%
    Wide Bands Range Expansion 3.91%
    Gapped Up Strength 3.91%
    Below Lower BB Weakness 3.91%
    Lower Bollinger Band Touch Weakness 3.91%
    Oversold Stochastic Weakness 3.91%
    Older End-of-Day Signals for FBIOP ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 9 hours ago
    Rose Above Previous Day's High about 9 hours ago
    Up 5% about 9 hours ago
    Up 3% about 9 hours ago
    Up 2% about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    FBIOP Chart by TradingView
    Basic chart:

    Profile

    Fortress Biotech Inc is a biopharmaceutical company. The Company is engaged in the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Life Sciences Immunotherapy Autoimmune Disease Virotherapy Treatment Of Autoimmune Disease

    Is FBIOP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
    Apr 24 Avenue Therapeutics Announces Reverse Stock Split
    Mar 28 Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
    Mar 28 Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
    Mar 25 Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
    Mar 18 Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
    Mar 18 Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
    Mar 18 Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors
    Mar 15 Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
    Mar 15 Avenue Therapeutics Receives Positive Listing Determination from Nasdaq
    See more FBIOP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.89
    52 Week Low 5.7005
    Average Volume 11,253
    200-Day Moving Average 12.79
    50-Day Moving Average 15.67
    20-Day Moving Average 15.70
    10-Day Moving Average 14.67
    Average True Range 0.89
    RSI (14) 37.11
    ADX 36.73
    +DI 12.08
    -DI 32.79
    Chandelier Exit (Long, 3 ATRs) 15.21
    Chandelier Exit (Short, 3 ATRs) 15.24
    Upper Bollinger Bands 18.24
    Lower Bollinger Band 13.15
    Percent B (%b) 0.13
    BandWidth 32.44
    MACD Line -0.58
    MACD Signal Line -0.21
    MACD Histogram -0.3696
    Fundamentals Value
    Market Cap 783.31 Million
    Num Shares 56.7 Million
    EPS -0.86
    Price-to-Earnings (P/E) Ratio -16.01
    Price-to-Sales 1.20
    Price-to-Book 0.00
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 14.79
    Resistance 3 (R3) 14.79 14.47 14.63
    Resistance 2 (R2) 14.47 14.22 14.47 14.57
    Resistance 1 (R1) 14.14 14.07 14.31 14.14 14.52
    Pivot Point 13.82 13.82 13.90 13.82 13.82
    Support 1 (S1) 13.50 13.58 13.66 13.50 13.12
    Support 2 (S2) 13.18 13.42 13.18 13.07
    Support 3 (S3) 12.85 13.18 13.01
    Support 4 (S4) 12.85